<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-BK9RM8K4/a6472f6c-eb1c-4dc0-92e5-5c835ab1461e/PDF"><dcterms:extent>123 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-BK9RM8K4/2ba38f8e-751b-4068-b3ea-122b184c09e0/TEXT"><dcterms:extent>24 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-BK9RM8K4"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>2011</dcterms:issued><dc:creator>Kolšek, Borut</dc:creator><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">letnik:50</dc:format><dc:format xml:lang="sl">str. 441-446</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:29426137</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-BK9RM8K4</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="sl">Antihipertenzivi</dc:subject><dc:subject xml:lang="en">Antihypertensive Agents</dc:subject><dc:subject xml:lang="sl">arterijska hipertenzija</dc:subject><dc:subject xml:lang="en">Blood Pressure Determination</dc:subject><dc:subject xml:lang="en">Blood Pressure Monitoring, Ambulatory</dc:subject><dc:subject xml:lang="en">Cerebrovascular Disorders</dc:subject><dc:subject xml:lang="sl">Cerebrovaskularne motnje</dc:subject><dc:subject xml:lang="en">Coronary Disease</dc:subject><dc:subject xml:lang="sl">Dejavniki tveganja</dc:subject><dc:subject xml:lang="en">Diagnosis</dc:subject><dc:subject xml:lang="en">diagnostika</dc:subject><dc:subject xml:lang="en">Drug Therapy</dc:subject><dc:subject xml:lang="sl">Hipertenzija</dc:subject><dc:subject xml:lang="en">Hypertension</dc:subject><dc:subject xml:lang="sl">Koronarna bolezen</dc:subject><dc:subject xml:lang="sl">Krvni pritisk, ambulantno merjenje</dc:subject><dc:subject xml:lang="sl">Krvni pritisk, merjenje</dc:subject><dc:subject xml:lang="sl">krvni tlak</dc:subject><dc:subject xml:lang="sl">meritve</dc:subject><dc:subject xml:lang="en">Risk Factors</dc:subject><dc:subject xml:lang="en">Therapeutic Use</dc:subject><dc:subject xml:lang="sl">variabilnost</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q844935" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Variabilnost krvnega tlaka| Blood pressure variability|</dc:title><dc:description xml:lang="sl">Several publications in scientific magazines try to revive the interest in thefrequently overlooked importance of the variability and the consequences ofblood pressure variability on cardiovascular events. Despite the fact that arterial hypertension is the most prevalent risk factor, which can be controlled by means of drugs, the development of target organ damage destruction and cardiovascular events has not been fully explained yet. There is a growing body of evidence that the level of blood pressure variability, which should be determined as aroutine, plays an important role in this process. Currently, it is the method of 24-hour ambulatory blood press ure monitoring that has proved as the most useful one. There is the need of additional research, which will explain the causes/consequences ofblood pressure variability and its treatment. It is undoubtedly necessary to redu cethe mean blood pressure, however, patients with consistently reduced blood pressure have better prognosis. The characteristics ofindividual antihypertensive drugs and their effect on blood pressure variability are be coming more and more important</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-BK9RM8K4"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-BK9RM8K4" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-BK9RM8K4/a6472f6c-eb1c-4dc0-92e5-5c835ab1461e/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-BK9RM8K4/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-BK9RM8K4" /></ore:Aggregation></rdf:RDF>